Jason Novak's practice was specifically created to focus on advising entities, both large and small, on the various legal issues that can arise with emerging technologies in the healthcare, food and life sciences industries, with a particular and targeted focus on "convergence" technologies (e.g., digital health, personalized/precision medicine, alternative protein) that operate at the intersection of multiple industries.  

Jason has extensive experience in IP and data rights strategy. For data rights, Jason advises clients on transactions, protection and general strategy. On the IP front, Jason's experience extends to patent portfolio management, preparation and prosecution, oppositions, counseling, licensing and technology transactions, in and out-licensing, freedom-to-operate, various types of due diligence, IP training, risk recognition and management and dispute resolution.

Prior to starting this practice, Jason was IP Director for Thermo Fisher Scientific, where he managed worldwide IP needs in genetic sciences instrumentation and software (e.g., qPCR, dPCR, capillary electrophoresis). Jason managed large IP portfolios, a team of agents and attorneys, licensing programs, various diligence needs, various IP-related transactions and foreign and domestics patent challenges.

Before moving into the legal industry, Jason was a research engineer for a leading food product company, where he led numerous product and process redesigns, reformulations and launches. This cross-functional role required interaction and experience with operations, finance, marketing and regulatory areas, contributing to Jason's ability to deal with various corporate functions from both an R&D and legal perspective.